NCT04755777View on ClinicalTrials.gov

Provider Perspectives on Beta-lactam Therapeutic Drug Monitoring Programs in the Critically Ill

CompletedOBSERVATIONAL
Enrollment

138

Participants

Timeline

Start Date

October 22, 2020

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
SepsisCritical Illness
Trial Locations (3)

4029

Royal Brisbane and Women's Hospital, Herston

32610

UF Health Shands, Gainesville

55902

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04755777 - Provider Perspectives on Beta-lactam Therapeutic Drug Monitoring Programs in the Critically Ill | Biotech Hunter | Biotech Hunter